116
Views
14
CrossRef citations to date
0
Altmetric
Review

Indications and limitations of third-generation aromatase inhibitors

&
Pages 723-739 | Published online: 30 Apr 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Per Eystein Lønning. (2010) Evolution of endocrine adjuvant therapy for early breast cancer. Expert Opinion on Investigational Drugs 19:sup1, pages S19-S30.
Read now

Articles from other publishers (13)

Merve Ertas, Zafer Sahin, Barkin Berk, Leyla Yurttas, Sevde N. Biltekin & Seref Demirayak. (2018) Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation. Archiv der Pharmazie 351:3-4, pages 1700272.
Crossref
Gurusamy Umamaheswaran, Dharanipragada Kadambari, Annan Sudarsan Arun Kumar, Mohan Revathy, Raj Anjana, Chandrasekaran Adithan & Steven Aibor Dkhar. (2015) Polymorphic genetic variations of Cytochrome P450 19A1 and T-cell leukemia 1A genes in the Tamil population. Environmental Toxicology and Pharmacology 39:1, pages 102-113.
Crossref
Joohyun WooWoosung Lim. (2014) Endocrine Therapy for Breast Cancer. The Ewha Medical Journal 37:2, pages 83.
Crossref
Diane M. Biskobing. 2013. Osteoporosis. Osteoporosis 93 107 .
P. E. Lonning & H. P. Eikesdal. (2013) Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved. Endocrine Related Cancer 20:4, pages R183-R201.
Crossref
Adnan Aydiner. (2013) Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women. The Breast 22:2, pages 121-129.
Crossref
Philipp Y. Maximov, Russell E. McDaniel & V. Craig JordanPhilipp Y. Maximov, Russell E. McDaniel & V. Craig Jordan. 2013. Tamoxifen. Tamoxifen 69 84 .
Shayne Cox GadAkm Hossain & Jame Abraham. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
P.E. Lønning. (2011) The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum. Annals of Oncology 22:3, pages 503-514.
Crossref
J Geisler. (2011) Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole – of clinical importance?. British Journal of Cancer 104:7, pages 1059-1066.
Crossref
Jürgen Geisler & Per E. Lønning. (2010) Impact of aromatase inhibitors on bone health in breast cancer patients. The Journal of Steroid Biochemistry and Molecular Biology 118:4-5, pages 294-299.
Crossref
Mitch DowsettJack CuzickJim IngleAlan CoatesJohn ForbesJudith BlissMarc BuyseMichael BaumAman BuzdarMarco ColleoniCharles CoombesClaire SnowdonMichael GnantRaimund JakeszManfred KaufmannFrancesco BoccardoJon GodwinChristina DaviesRichard Peto. (2010) Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen. Journal of Clinical Oncology 28:3, pages 509-518.
Crossref
Per E. Lønning. (2008) Endocrine Therapy and Bone Loss in Breast Cancer: Time to Close in the RANK(L)?. Journal of Clinical Oncology 26:30, pages 4859-4861.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.